The MHRA-approved product information for Wegovy notes that gastrointestinal disorders are among the most frequently reported adverse reactions, with nausea affecting approximately 44% of patients in clinical trials, though this typically diminishes over time as tolerance develops
In response to hyperglycemia, GIP exhibits no effect on glucagon responses while potentiating insulin secretion
As Judge Marston put it, any Plaintiff claiming to suffer (or have suffered) from gastroparesis, must show that their diagnosis is based on a properly performed gastric emptying study. That standard may narrow the pool of viable claims, unfairly, we would argue
Results are different for everyone
are supported by the National Natural Science Foundation of China (82088102, 81970728 and 81941017) and the Shanghai Municipal Education CommissionGaofeng Clinical Medicine Grant Support (20161307 and 20152508 Round 2)